Results

1–10 of 167 results for outcomes

National vs International Outcomes and Practice Patterns of Intravitreal Anti-VEGF Injections for Retinopathy of Prematurity
Nimesh A. Patel, MD
Annual Meeting Talks
2022
Baseline Factors Associated With 1-Year Outcomes in Phase III Comparison of SB11 (Approved Ranibizumab Biosimilar) With Reference Ranibizumab in nAMD
Neil M. Bressler, MD
Annual Meeting Talks
2022
Outcomes of Patients with DME and Baseline BCVA 20/50 or Worse or 20/40 or Better Treated with Aflibercept 8 mg and 2 mg in the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
Updates from the Field
2024
Fibrin Glue–Assisted Retinopexy for Rhegmatogenous Retinal Detachments: GUARD Study; Long-Term Outcomes of a New Surgical Technique With No Silicone Oil or Gas Tamponade
Mudit Tyagi, MS, FASRS
Annual Meeting Talks
2022
Analysis of the Long-term Visual Outcomes of ForeseeHome Remote Telemonitoring.
Michael J. Elman, MD
Annual Meeting Talks
2022
Subretinal Pneumatic Displacement Without Tissue Plasminogen Activator for Submacular Hemorrhage: One-year Outcomes
Marwan Abdulaal, MD
Annual Meeting Talks
2022
Outcomes of Pars Plana Vitrectomy Alone vs Combined Scleral Buckling Plus Pars Plana Vitrectomy for Primary Retinal Detachment
Luis J Haddock, MD
Annual Meeting Talks
2022
Higher Order OCT Feature Assessment of the Impact of Fluid Dynamics on Visual Acuity in Neovascular AMD in a Phase III Clinical Trial: The Importance of Outer Retinal Integrity
Justis P. Ehlers, MD, FASRS
Annual Meeting Talks
2022
Surgical Outcomes of Scleral Buckling for Rhegmatogenous Retinal Detachment Using the NGENUITY 3-Dimensional Visualization System With a Guarded Light Pipe
John B. Miller, MD
Annual Meeting Talks
2022
Association Between Dysfunctional Complement Factor I: Rare Variant Status and Progression to Advanced AMD Outcomes
Johanna M. Seddon, MD, ScM, FARVO, FASRS
Annual Meeting Talks
2022